DME strategy · Private-pay retail · Manufacturer GTM
The DME model is changing.
Build what’s next.
BlueLine helps independent providers and medical product manufacturers make better operating, retail, product, and channel decisions.
The market brief · 2026
The pressure is real. The response should be deliberate.
Reimbursement pressure, consolidation, national contracts, and changing buyer expectations are colliding. The strategic question is where your business can create value that scale alone cannot.
Competitive bidding
Round 2028 changes the planning horizon now.
Bid eligibility, licensing, accreditation, pricing, and service-area strategy cannot be a last-minute exercise.
CMS guidance ↗National scale
Reach is becoming a qualification—not just an advantage.
National contracts raise the stakes for independents deciding where to compete, partner, specialize, or build private-pay strength.
CMS licensing requirements ↗Consolidation
Private capital is redrawing the competitive map.
PE-backed platforms and strategic buyers are consolidating categories. Independent operators need a deliberate answer to scale.
DME consolidation report ↗Buyer adoption
New products carry a higher burden of proof.
Healthcare buyers want evidence that reduces risk: ROI, demonstrations, outcomes, reliability, and a credible reason to change.
HME Business research ↗Market observations are for strategic planning, not legal, regulatory, or investment advice. Sources are linked for direct review.
For DME providers & retailers
Move from reimbursement dependence to a retail model customers trust.
Private pay is not a product rack or a payment type. It is an operating model: what you carry, how you price, how the team communicates value, how referrals experience the change, and how leaders measure what is working.
Private-pay retail assessment
A practical review of assortment, pricing, customer experience, referral relationships, staffing, workflows, and the numbers behind the model.
Growth & operating model
Turn a concept that works in one location into repeatable systems, clear ownership, useful reporting, and management discipline.
Strategic decision support
Work through competitive bidding, payer changes, acquisitions, new categories, technology decisions, or a shift away from reimbursement dependence.
For manufacturers & vendors
A good product still needs a market.
As retailer expectations change, a new feature is not enough. BlueLine brings the provider, retailer, and consumer perspective into product design, channel selection, commercial positioning, launch, and field adoption.
Product & category design
Bring operator, retailer, and consumer reality into features, assortment logic, price architecture, packaging, and the product brief.
Channel & GTM strategy
Choose the right route across independent DME, regional retailers, national accounts, direct-to-consumer, referral, and hybrid models.
Launch & field adoption
Build the commercial story, pilot, demonstrations, training, objections, feedback loops, and measures that help an unfamiliar product earn trust.
What healthcare buyers say they need
Difference must arrive with proof.
WTWH Media M2 Research included 905 complete and 252 partial responses across healthcare decision-makers. Review the research ↗
Ways to work together
Defined enough to understand. Flexible enough to be useful.
Start with the size of engagement the decision deserves. No forced transformation program and no sales theater.
Decision Session
A focused working session to frame one consequential decision, pressure-test assumptions, and leave with a clear next move.
Best for: a live issue that has become too important to guess at.Private-Pay Retail Assessment
A structured look at the customer journey, assortment, economics, workflows, people, reporting, and growth constraints.
Best for: providers moving from reimbursement counter to real retail.Manufacturer GTM Sprint
An operator-led review of product-market fit, channel, buyer story, retailer economics, launch proof, and adoption barriers.
Best for: manufacturers entering or expanding in HME retail.Executive Advisory
Ongoing access to experienced operating judgment as decisions arise—without creating another large consulting program.
Best for: leaders who need a trusted outside perspective over time.Selected work
Built in the real world.
Representative work is described without inventing financial outcomes or client claims. The value is experienced pattern recognition and the ability to turn it into an operating decision.
Retail operations
Building the system behind regional growth
A growing DME retailer needed to expand without losing the customer experience or depending on one person to hold the operation together.
Built workflows, reporting, technology, staff development, retail execution, and a multi-site management structure under private-equity ownership.
The operating playbook supported growth from two locations to ten and made execution more visible, teachable, and repeatable.
Private-pay transformation
Turning a reimbursement counter into a retail model
Traditional DME habits were not designed for customers comparing options and paying with their own money.
Connected category strategy, pricing, floor experience, staff behavior, referral communication, and management reporting.
A coordinated retail system built around trust, choice, staff confidence, and measurable execution—not simply more products on display.
Product & category creation
Helping unfamiliar mobility products earn adoption
Early carbon-fiber power chairs and scooters offered real consumer benefits, but the channel needed more than a material story.
Helped shape product decisions, positioning, channel choice, retailer education, and the consumer use case; also influenced lift-chair features now common across major suppliers.
New categories reached the floor with a stronger connection between product design, retailer economics, field education, and consumer value.
Why BlueLine
Operator judgment, not a borrowed framework.
“I have built the systems, led the teams, read the numbers, opened the locations, managed the manufacturer relationships, and lived with the results.”
BlueLine is led by Evan Conlon, an operator who helped build AZ MediQuip from two locations into a ten-location regional retailer under private-equity ownership, then carried that experience into manufacturer representation, analytics, technology, retail strategy, and advisory work.
The hockey influence is simple: disciplined observation, honest feedback, and knowledge transfer can help a capable team perform at a much higher level. Here, that work is focused on stronger businesses and better lives for patients.
Common questions
Before we talk.
Do I need a complete brief before we talk?+
No. The most useful starting point is often the decision, constraint, or opportunity you are still trying to define.
Is BlueLine only for multi-location companies?+
No. The work is relevant to independent operators, emerging retail concepts, regional providers, and manufacturers that need a grounded view of the channel.
Do you sell products or represent a software platform?+
No. BlueLine is independent advisory. Recommendations start with the business, the customer, and the decision—not a product quota.
Can an engagement stay small?+
Yes. A single decision session or focused sprint may be enough. Broader support is available when the issue genuinely requires it.
A useful first conversation
Bring the decision.
Skip the sales process.
Tell me whether you are approaching this as a provider, retailer, manufacturer, or vendor—and what has become too important to guess at.